KnowTheStock
Log inCreate free account

AMGEN Inc.

AMGN
S&P 500Dow 30Nasdaq 100Research and Development in Biotechnology (except Nanobiotechnology) · NASDAQ
$360.55last close · market cap 196.14 Billion
Compare with…
62.0SCORE / 100
Our verdictHOLDStrong Growth and ImprovingQtr Ending 2026-06-30 · trend positive

Why Hold

Income statement and cash flow are strong; balance sheet is weak.

Next earnings: 2026-11-03 (AMC), EPS Forecast: $5.72

What is strong
  • Operating Income Growth is 39.48%
  • Net Income Growth is 32.09%
  • Earnings Per Share (EPS) Growth is 31.64%
  • Net Margin is 22.95%
  • Debt Ratio is 0.29
  • Capital Expenditure is Low
  • Net Increase in Cash is Positive
What to watch
  • Revenue Growth is 9.1%
  • Current Asset to Current Liability Ratio is 1.37
  • Current Debt to Net Income Ratio is 2.29
  • Total Debt to Total Assets Ratio is 0.66
  • Cash from Operations Growth is 3.87%
  • Investment Risk is High

What changed

Score by quarter

Upgraded from Sell to Hold in the Jun 2025 quarter: 57.0 → 58.3 (+1.3). This quarter: +0.8.

40506070Sep 2022Jun 2026

What the score is made of

Income statement75.3 -0.0
Balance sheet37.1 +0.0
Cash flow62.0 +5.1

Change vs previous quarter.

Key numbers · latest quarter

Revenue (TTM)38.09 Billion9.10 % growth
EPS16.1031.64 % growth
Profit margin22.95 %Profit per $1 of sales
P-E ratio—Not available
Market cap196.14 BillionShares × price
Debt-equity ratio5.37Leverage
Dividend9.80Per share, annual
Next earnings2026-11-03AMC · EPS forecast $5.72
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.

About AMGEN Inc.

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.

CEO
Robert Bradway
Employees
25,200
Sector
Professional, Scientific, and Technical Services
Exchange
NASDAQ
amgen.com

Similar stocks

Loading…